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Abstract. Background/Aim: One of the most studied bacterial
resistance mechanisms is the resistance related to multidrug
efflux pumps. In our study the pump activity of the Escherichia
coli K-12 AG100 strain expressing the AcrAB-TolC pump
system was investigated at pH 7 and pH 5 in the presence of
the efflux pump inhibitor (EPI) promethazine (PMZ). Materials
and Methods: The EPI activity was assessed by real-time
fluorimetry. The influence of PMZ treatment on the relative
expression of the pump genes acrA, acrB and their regulators
marA, marB, marR, the stress genes soxS, rob, as well as the
bacterial growth control genes ftsI, and sdiA were determined
by RT-qPCR. Results: The EPI activity of PMZ was more
effective at neutral pH. The PMZ treatment induced a
significant stress response in the bacterium at acidic pH by the
up-regulation of genes. Conclusion: The genetic system that
regulates the activity of the main efflux pump is pH-dependent.
Bacterial infections that are resistant to two or more classes of
antibiotics are deemed multidrug resistant (MDR). The
frequency of MDR clinical isolates is global and renders
commonly available antibiotics useless. Among the many ways
by which the MDR phenotype arises, the over-expression of
MDR transporters promotes the expelling of antibiotics and other
toxins from the bacterium prior to their reaching their targets (1). 
The main efflux pump of E. coli K-12 AG100 is the AcrAB-
TolC system which is either transiently over-expressed in the
MDR isolate or permanently over-expressed as a
consequence of mutations of the regulatory genes that
encode the pump (2). 
The AcrAB-TolC efflux pump system consists of three
proteins, the AcrB transporter and two fusion proteins that
attach the AcrB to the plasma membrane. The AcrB transporter
recognizes and binds the toxic agent (antibiotic) and releases
it to the TolC channel to which it is connected. The AcrB is
attached to the plasma membrane via the two fusion proteins
whose peristaltic action drives water through the transporter
and TolC channel, ultimately releasing the agent to the
environment at the junction of TolC to the outer membrane,
which consists partly of lipopolysaccharides (LPS). Transport
of drugs from the cell to the outside by this system is coupled
to proton motive force (PMF) from the periplasm to the
cytoplasm. Proton binding and release takes place in the
transmembrane domain. The energy transduction and substrate
transport seem to be spatially separated (3-5). The activity of
the AcrAB-TolC pump in E. coli K-12 AG100 is inhibited by
all phenothiazines studied to date. Whether inhibition is direct
or indirect is not fully understood. Nevertheless, because the
inhibition of the over-expressed efflux pump renders the MDR
bacterium susceptible to antibiotics to which it was initially
resistant, phenothiazines may have a clinical use as adjuvants.
Such examples are PMZ that reduced the frequency of
pyelonephritis in children treated with gentamicin, and
thioridazine that was effective against XDR-Mycobacterium
tuberculosis in combination with antibiotics to which the
isolate was initially resistant (6). The activity of the AcrAB-
TolC system at neutral pH depends on metabolic energy
whereas at pH of 5 no metabolic energy is needed. Moreover,
the effect of antibiotics at acidic pH is less pronounced. The
effect of pH on the growth of bacteria is well known regarding
the stress promoted at acidic conditions (7). The expression of
the AcrAB-TolC efflux pump system is controlled by
transcriptional regulators, such as MarA, MarB, MarR and the
stress proteins SoxS and Rob (8-11). In addition, the bacterial
growth is controlled by SdiA and its over-expression results in
the over-expression of the AcrAB-TolC system (12). 
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The bacterial cell division is controlled by the transpeptidase
FtsI required for synthesis of peptidoglycan (13). The role of
phenothiazines as EPIs of the AcrAB-TolC pump has been
studied at neutral pH under conditions that permit the
phenothiazine to affect the activity of the pump, however,
these compounds have not been studied at acidic pH (3, 14).
It is the intent of the study to describe the expression of genes
that are known to be affected at neutral and acidic pH and
determine the effect of PMZ on the expression of these genes.
Materials and Methods
Reagents and media. Promethazine (EGIS), ethidium bromide (EB) and
Luria-Bertani (LB) broth were purchased from Sigma-Aldrich Chemie
GmbH (Steinheim, Germany). Mueller Hinton (MH) broth was
purchased from Scharlau Chemie S. A. (Barcelona, Spain). Sterile
glucose solution (40%) was applied in the experiments (PannonPharma,
Hungary). The pH was adjusted to 5.0 and 7.0. In the case of PMZ the
solvent for the stock solution was distilled water. Phenothiazines are
affected by light, thus, PMZ was protected from it (15). The optical
properties of the broth with and without PMZ were not altered. 
Bacterial strain. The wild-type Escherichia coli K-12 AG100 strain
[argE3 thi-1 rpsL xyl mtl Δ(gal-uvrB) supE44] expresses the
AcrAB-TolC efflux pump at its basal level (16, 17). This strain was
kindly provided by Prof. Dr. Hiroshi Nikaido (Department of
Molecular and Cell Biology and Chemistry, University of
California, Berkeley, CA, USA). 
Determination of minimum inhibitory concentrations by
microdilution method. The minimum inhibitory concentration (MIC)
of PMZ was determined according to Clinical and Laboratory
Standard Institute (CLSI) guidelines using MH media at pH 5 and
pH 7. Briefly, the bacterial strain was separately cultured in broth
of pH 5 and pH 7 overnight at 37˚C. On the following day, the
determination of MIC was carried out using broth dilution method
in 96-well plates and the plates were incubated for 18 h at 37˚C.
Determination of growth curves at pH 5 and pH 7. The growth
curves of the E. coli K-12 AG100 strain were determined by
measuring the optical density (OD600) at pH 5 and pH 7 in LB broth
with and without 25 μg/ml of PMZ. The bacterial cultures were
incubated for further 24 h at 37˚C with shaking (220 rpm) and the
optical density was monitored at 600 nm. In addition, we
determined the colony forming units (CFUs) at various time points
(0, 2, 5, 8, and 24 h) on LB agar plates.
Phenothiazines promote the elongation and subsequent filamention
of the bacterium (18). This morphological response affects the
interpretation of the results that define growth and optical properties
of the culture. From the MIC data obtained at pH 5 and pH 7, the
concentration of PMZ that produced no obvious effect on the
viability, elongation or filamentation of E. coli K-12 AG100 at both
acidic and neutral pH was determined. 
Real-time EB accumulation assay. The effect of PMZ on the real-time
accumulation of EB in the presence and absence of glucose (0.4%)
was assessed by an automated EB method as described previously
(19), using a LightCycler real-time thermocycler (LightCycler 1.5;
Roche, Indianapolis, IN, USA). The final concentrations of PMZ and
EB were 25 μg/ml and 1 μg/ml, respectively. The capillaries were
placed into a carousel (Roche) and the fluorescence was monitored
at the FL-2 channel every minute on a real-time basis. From the real-
time data, the activity of the compound, namely the relative
fluorescence index (RFI) of the last time point (minute 30) of the EB
accumulation assay was calculated according to the formula:
where RFtreated is the relative fluorescence at the last time point of
the EB retention curve in the presence of an inhibitor, and
RFuntreated is the relative fluorescence at the last time point of the
EB retention curve of the untreated solvent control. The solvent was
distilled water in the case of PMZ.
Total RNA isolation. The E. coli K-12 AG100 strain was cultured
overnight in LB broth at pH 5 and pH 7 at 37˚C with shaking
(OD600: 0.6). Bacterial suspensions were prepared with and without
PMZ (25 μg/ml) in 3.5 ml of LB medium at pH 5 and pH 7 and
were incubated at 37˚C with shaking. The total RNA was isolated
at various time points (0, 1, 2, 4, 8, and 18 h). The RNA preparation
was carried out in an RNase-free environment using the NucleoSpin
RNA kit (Macherey Nagel, Germany), according to the
manufacturer’s instructions. Purified RNA was stored in RNase-free
water in nuclease-free collection tubes and was maintained at –20˚C
until quantification was performed. The concentration of the
extracted RNA templates was assessed by spectrophotometry
SmartSpec™ Plus at 260 nm (Bio-Rad, Hercules, CA, USA).
Relative gene expression analyses by real-time reverse transcriptase
quantitative polymerase chain (RT-qPCR) reaction. The relative
gene expression levels were determined at pH 5 and pH 7 in the
presence and absence of PMZ. The E. coli K-12 AG100 strain was
cultured in LB at pH 5 and pH 7 and total RNA was isolated at
various time points (after 0, 1, 2, 4, 8, and 18 h). The relative
expression levels of the efflux pump genes, their regulators, stress
genes and genes involved in cell wall biosynthesis and quorum
sensing were determined by RT-qPCR (20, 21) (Table I), using
CFX96 Touch real-time PCR detection system (BioRad), strictly
following the manufacturer’s recommendations for the
SensiFAST™ SYBR No-ROX One-Step Kit (Bioline GmbH,
Luckenwalde, Germany). Briefly, each well of the 96-well
microtiter plate contained 20 μl as follows: 10 μl of the 2x
SensiFAST™ SYBR No-ROX One-Step Mix, 0.2 μl Reverse
Transcriptase, 0.4 μl RiboSafe RNase Inhibitor, 5.4 μl
Diethylpyrocarbonate (DEPC)-treated water, 500 nM of each primer
and approximately 20 ng of total RNA in RNase-free water.
Thermal cycling was initiated with a denaturation step of 5 min at
95˚C, followed by 40 cycles each of 10 s at 95˚C, 30 s at 57˚C and
20 s at 72˚C. The relative quantities of the mRNA of each gene of
interest were determined by the use of the ΔΔCT method. Gene
transcript levels were normalized against the E. coli housekeeping
gene GAPDH measured in the same sample. The equation 2–ΔΔCT
allows the relative quantification of differences in each gene’s
expression level between two samples, the sample of interest and a
calibrator or reference sample. The relative gene expression analysis
was calculated, according to the following formulas: 
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ΔCT=CT (gene of interest) – CT (reference gene) 
ΔΔCT=ΔCT (PMZ treated) – ΔCT (PMZ untreated) 
Results
The MIC of PMZ was determined using MH broth at pH 5
and pH 7 on E. coli K-12 AG100 strain expressing the
AcrAB-TolC efflux pump system. The MIC of PMZ was 
200 μg/ml at pH 5 and 7. 
The growth of the E. coli K-12 AG100 strain at pH 5 and
pH 7 in LB broth with and without the lowest concentration
of PMZ that had a nominal effect on growth for 24 h is
shown in Figure 1. Briefly, the growth of PMZ treated
bacterial culture was slower at both pH, although the effect
on growth was greater at pH 7. 
The effect of PMZ on the real-time accumulation of EB
was assessed using an automated EB method in the presence
and absence of 0.4% glucose. The real-time accumulation
curves demonstrated a higher intracellular EB concentration
without glucose at pH 7 compared to the EB accumulation
at pH 5. The intracellular concentration of EB increased in
the presence of PMZ at neutral pH, however the PMZ treated
sample exhibited lower EB accumulation at acidic pH. In the
case of PMZ treated sample the intracellular EB
accumulation was significantly higher at pH 7 compared to
pH 5. The efflux pump inhibitor PMZ could exert a more
potent EPI effect at neutral pH (Figure 2). 
The influence of PMZ treatment was examined on the
relative expression of the efflux pump genes (acrA, acrB)
and their regulators at neutral and acidic pH. The RT-
qPCR results showed that the external environment can
influence the activity of efflux pumps. In the case of
acidic pH every gene except for soxS exhibited a
decreased gene expression pattern in the first 1-2 h. After
this period of time the gene expression levels started to
increase. Increase in gene expression was detected in the
cases of the efflux pump genes acrA and B, as well as in
marR regulator, soxS stress gene and QS regulator sdiA
after the 18th hour (Figure 3). At neutral pH almost all
genes except for marB and marR exhibited a decreased
expression pattern in the first 1-2 h. Significant gene
expression could be observed in the expression levels of
acrA, acrB, and marA genes in the 18th hour, of marB in
the 1st hour and of ftsI after 4 h. Initially the efflux pump
genes acrA and acrB were down-regulated, but at the end
of the culturing period (18th hour) both genes were up-
regulated (Figure 3).
Nové et al: pH Dependence of Promethazine in E. coli
67
Table I. Primers used in the RT-qPCR.
Gene                                         Primer sequence (5’-3’)                                                         Amplicon size (bp)                                   Reference
                                                                                                                                                                 
marA                                         CATAGCATTTTGGACTGGAT                                                        187                                                     (20)
                                                 TACTTTCCTTCAGCTTTTGC
marB                                         ATAGCAGCTGCGCTTATTC                                                           154                                                     (20)
                                                 ACTTATCACTGCCAGTACCC
marR                                         AGCGATCTGTTCAATGAAAT                                                       170                                                     (20)
                                                 TTCAGTTCAACCGGAGTAAT
acrA                                          CTTAGCCCTAACAGGATGTG                                                       189                                                     (20)
                                                 TTGAAATTACGCTTCAGGAT
acrB                                          CGTACACAGAAAGTGCTCAA                                                     183                                                     (20)
                                                 CGCTTCAACTTTGTTTTCTT
soxS                                          CCATTGCGATATCAAAAATC                                                        210                                                     (20)
                                                 ATCTTATCGCATGGATTGAC
rob                                            GTCGTCTTTATCCTGACTCG                                                        189                                                     (20)
                                                 TTTGTCACCCTGGAAGATAC
ftsI                                             GGCGCTGGTTTATCGCGAAC                                                      380                                                     (12)
                                                 CCAGCTTGGAAACACCGAC
sdiA                                           CTGATGGCTCTGATGCGTTTA                                                     163                                               This study
                                                 TCTGGTGGAAATTGACCGTATT
GAPDH                                    ACTTACGAGCAGATCAAAGC                                                      170                                                     (20)
                                                 AGTTTCACGAAGTTGTCGTT
marA: Multiple resistance antibiotic protein A; marB: multiple resistance antibiotic protein B; marR: multiple resistance antibiotic protein R; acrA:
acridin resistance protein A; acrB: acridin resistance protein B; soxS: superoxid stress protein; rob: right origin-binding protein; ftsI: peptidoglycan
D,D-transpeptidase FtsI; sdiA: quorum-sensing transcriptional activator; GAPDH: glyceraldehyde-3-phospate dehydrogenase.
Discussion
The virulence and adaptation of bacteria to the
environmental conditions depend on the stress response
induced by different factors, such as reduced nutrient source
and starvation, pH, low and high osmolarity (22). The
survival and colonization of enteric bacteria depend on
extreme pH tolerance (23). Before the pathogenic bacteria
reach the alkaline pH of the small intestine they must survive
the acidic pH of the stomach (24). According to our results,
the pH can influence the accumulation and efflux of the
RND pump substrate EB. Applying resistance modifiers in
our experimental model, the consideration of different pH
received special attention in order to mimic the physiological
conditions in the gastrointestinal tract (25). 
In order to restore survival of E. coli K-12 AG100 and
maintain the conditions of cell growth, the acidic stress and
PMZ treatment have to be overcome by different cellular
mechanisms, such as proton pumps and induce a buffering
effect through increasing the concentration of intracellular
alkaline compounds (26). In addition, E. coli K-12 AG100
has two major energy sources, and the ATP synthesis. The
latter is generated via the respiratory chain and is used
mainly for ATP synthesis and various membrane transports
(27). At acidic pH, the ATP supply is crucial for the survival
of E. coli. At pH 7, E. coli cells are able to maintain a
constant internal pH over a range of external pH values from
6.7 to 7.9 (28).
In the EB accumulation assay the EPI activity of PMZ was
less effective at acidic pH compared to neutral pH. From this,
in vivo 34: 65-71 (2020)
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Figure 1. The growth curves of E. coli K-12 AG100 strain were determined at pH 5 (A, B) and pH 7 (C, D) in LB broth in the presence and absence
of 25 μg/ml of PMZ. Graphs A and C show the growth curves by measuring the optical density (OD600) at pH 5 and pH 7, respectively. Graphs B
and D show the growth curves by counting the CFUs at pH 5 and pH 7, respectively. The growth of PMZ treated bacterial culture was slower at
pH 5 compared to pH 7. The growth of bacterial culture was more rapid at pH 7, moreover after 8 h of culturing the declination phase of the
bacterial culture could be detected at pH 7 (Graph D).
it can be concluded that the EPI activity of PMZ is pH-
dependent because the proton motive force provides a more
pronounced energy supply for the AcrB pump at pH 5. At acidic
pH the PMF is higher compared to the neutral pH, for this
reason the EB that accumulated in the presence of PMZ was
lower at pH 5. It has been demonstrated by Mulkidjanian and
coworkers that protons generated through metabolic pathways
are transported as hydronium ions via channels to the surface
of the cell where they are distributed and bound to reactive
groups of LPS. These hydronium ions are then transported to
the periplasm where they drive the efflux system, thus
promoting the rapid extrusion of the substrate (29).
In addition, the acidic pH and PMZ treatment induced a
significant stress response in E. coli, and this fact was
confirmed by the up-regulation of marB, marR, acrA, acrB,
soxS, ftsI, and sdiA genes at acidic pH compared to the
neutral pH. Interestingly, soxS exhibited a continuous
increase at pH 5, however, at pH 7 the soxS gene was down-
regulated until the end of the culturing period. It has to be
emphasized that the presented experimental setting applied
PMZ at a very low concentration, for which at pH 7 it does
not affect the stress genes in the wild type E. coli. For this
reason, the rob and ftsI genes required for the initiation of
replication and cell wall synthesis, respectively, have the
highest expression rate in the 4th hour of culture. In addition,
the expressions of ftsI and sdiA were higher at acidic pH
compared to neutral pH. The over-expression of the efflux
pump genes acrA and B at pH 5 and pH 7 indicates the
continuous removal of toxic substances by efflux pumps.
Finally, it can be concluded that the acidic pH and PMZ
treatment induced a stress response in the bacterium.
Taking our results together we were able to demonstrate
that efflux pump inhibitors are promising therapeutic options
that may help overcome bacterial multidrug resistance, as
well as improve the efficacy of combined antibacterial
chemotherapy using conventional antibiotics and EPIs. EPI
compounds can influence virulence factors (30), and should
be further studied using different bacterial model systems
imitating the environmental conditions present in the host
organism. 
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Figure 2. Accumulation of EB at pH 5 and pH 7 by E. coli K-12 AG100 in the presence and absence of glucose 0.4%, with and without 25 μg/ml
of PMZ. The real-time accumulation curves demonstrated a higher intracellular EB concentration without glucose at pH 7 compared to pH 5. The
intracellular concentration of EB was significantly higher in the presence of PMZ at pH 7, in addition the PMZ treated sample exhibited lower EB
accumulation at pH 5. The calculation of statistical significance and p-value was based on the relative fluorescence index (RFI) of the given sample.
The correlation is significant: p≤0.001 and p=0.005. 
Authors’ Contributions
GS conceived and designed the study. MN and AK performed the
laboratory work. MN, AK and GS wrote the article. JM and LA
revised the manuscript critically. All authors read and approved the
final manuscript.
Acknowledgements
This study was supported by the European Union and the State of
Hungary, co-financed by the European Social Fund in the framework
of TÁMOP 4.2.4. A/2-11-1-2012-0001 ‘National Excellence
Program’ and EFOP 3.6.3-VEKOP-16-2017-00009 and the János
Bolyai Research Scholarship of the Hungarian Academy of Sciences.
Annamária Kincses was supported by the ÚNKP-18-3 New National
Excellence Program of the Ministry of Human Capacities of
Hungary.
References
1 Weston N, Sharma P, Ricci V and Piddock LJV: Regulation of
the AcrAB-TolC efflux pump in Enterobacteriaceae. Res
Microbiol 169(7-8): 425-431, 2018. PMID: 29128373. DOI:
10.1016/j.resmic.2017.10.005 
2 Nikaido H and Takatsuka Y: Mechanisms of RND multidrug
efflux pumps. Biochim Biophys Acta 1794(5): 769-781, 2009.
PMID: 19026770. DOI: 10.1016/j.bbapap.2008.10.004
3 Sun J, Deng Z and Yan A: Bacterial multidrug efflux pumps:
Mechanisms, physiology and pharmacological exploitations.
Biochem Biophys Res Commun 453(2): 254-267, 2014. PMID:
24878531. DOI: 10.1016/j.bbrc.2014.05.090 
4 Wang Z, Fan G, Hryc CF, Blaza JN, Serysheva, II, Schmid MF,
Chiu W, Luisi BF and Du D: An allosteric transport mechanism
for the AcrAB-TolC multidrug efflux pump. eLife pii: e24905,
2017. PMID: 28355133. DOI: 10.7554/eLife.24905 
in vivo 34: 65-71 (2020)
70
Figure 3. Relative expression of genes involved in stress response on E. coli K-12 AG100 strain in the presence of 25 μg/ml of PMZ at pH 5 and
pH 7 at different time points (1-18 h). At the beginning of the culturing period most of the studied genes showed a decreased expression pattern.
Increase in gene expression level was detected in the cases of the acrA and B, marR, soxS, sdiA genes after the 18th hour at pH 5. Significant gene
expression could be observed in the expression levels of acrA, acrB, and marA genes in the 18th hour, of marB in the 1st hour and of ftsI after 4 h.
Initially the efflux pump genes acrA and acrB were down-regulated, but at the end of the culturing period (18th hour) both genes were up-regulated
at pH 7. The significant correlation is: p≤0.05. 
5 Pos KM: Drug transport mechanism of the AcrB efflux pump.
Biochim Biophys Acta 1794(5): 782-793, 2009. PMID:
19166984. DOI: 10.1016/j.bbapap.2008.12.015 
6 Varga B, Csonka A, Csonka A, Molnar J, Amaral L and Spengler
G: Possible biological and clinical applications of
phenothiazines. Anticancer Res 37(11): 5983-5993, 2017. PMID:
29061777. DOI: 10.21873/anticanres.12045 
7 Maurer LM, Yohannes E, Bondurant SS, Radmacher M and
Slonczewski JL: pH regulates genes for flagellar motility,
catabolism, and oxidative stress in Escherichia coli K-12. J
Bacteriol 187(1): 304-319, 2005. PMID: 15601715. DOI:
10.1128/JB.187.1.304-319.2005
8 Duval V and Lister IM: MarA, SoxS and Rob of Escherichia
coli - global regulators of multidrug resistance, virulence and
stress response. Int J Biotechnol Wellness Ind 2(3): 101-124,
2013. PMID: 24860636. DOI: 10.6000/1927-3037.2013.02.03.2
9 Okusu H, Ma D and Nikaido H: AcrAB efflux pump plays a
major role in the antibiotic resistance phenotype of
Escherichia coli multiple-antibiotic-resistance (Mar) mutants.
J Bacteriol 178(1): 306-308, 1996. PMID: 8550435. DOI:
10.1128/jb.178.1.306-308
10 Gupta A, Fuentes SM and Grove A: Redox-sensitive MarR
homologue BifR from Burkholderia thailandensis regulates
biofilm formation. Biochemistry 56(17): 2315-2327, 2017.
PMID: 28406615. DOI: 10.1021/acs.biochem.7b00103
11 Grove A: MarR family transcription factors. Curr Biol 23(4): R142-
143, 2013. PMID: 23428319. DOI: 10.1016/j.cub.2013.01.013 
12 Tavio MM, Aquili VD, Poveda JB, Antunes NT, Sanchez-
Cespedes J and Vila J: Quorum-sensing regulator sdiA and marA
overexpression is involved in in vitro-selected multidrug
resistance of Escherichia coli. J Antimicrob Chemother 65(6):
1178-1186, 2010. PMID: 20395215. DOI:10.1093/jac/dkq112 
13 Askoura M, Mottawea W, Abujamel T and Taher I: Efflux pump
inhibitors (EPIs) as new antimicrobial agents against
Pseudomonas aeruginosa. Libyan J Med 6, 2011. PMID:
21594004. DOI: 10.3402/ljm.v6i0.5870
14 Pages JM, Sandrine AF, Mahamoud A, Bolla JM, Davin-Regli A,
Chevalier J and Garnotel E: Efflux pumps of Gram-negative bacteria,
a new target for new molecules. Curr Top Med Chem 10(18): 1848-
1857, 2010. PMID: 20615189. DOI: 10.2174/156802610793176620
15 Pascu ML, Danko B, Martins A, Jedlinszki N, Alexandru T,
Nastasa V, Boni M, Militaru A, Andrei IR, Staicu A, Hunyadi A,
Fanning S and Amaral L: Exposure of chlorpromazine to 266
nm laser beam generates new species with antibacterial
properties: Contributions to development of a new process for
drug discovery. PLoS One 8(2): e55767, 2013. PMID:
23405212. DOI: 10.1371/journal.pone.0055767
16 Martins A, Machado L, Costa S, Cerca P, Spengler G, Viveiros
M and Amaral L: Role of calcium in the efflux system of
Escherichia coli. Int J Antimicrob Agents 37(5): 410-414, 2011.
PMID: 21419607. DOI: 10.1016/j.ijantimicag.2011.01.010 
17 Sugawara E and Nikaido H: Properties of AdeABC and AdeIJK
efflux systems of Acinetobacter baumannii compared with those
of the AcrAB-TolC system of Escherichia coli. Antimicrob
Agents Chemother 58(12): 7250-7257, 2014. PMID: 25246403.
DOI: 10.1128/AAC.03728-14
18 Amaral L and Lorian V: Effects of chlorpromazine on the cell
envelope proteins of Escherichia coli. Antimicrob Agents
Chemother 35(9): 1923-1924, 1991. PMID: 1952868. DOI:
10.1128/aac.35.9.1923
19 Viveiros M, Martins A, Paixao L, Rodrigues L, Martins M, Couto
I, Fahnrich E, Kern WV and Amaral L: Demonstration of intrinsic
efflux activity of Escherichia coli K-12 AG100 by an automated
ethidium bromide method. Int J Antimicrob Agents 31(5): 458-462,
2008. PMID: 18343640. DOI: 10.1016/j.ijantimicag.2007.12.015 
20 Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A,
Martins M, Pages JM and Amaral L: Antibiotic stress, genetic
response and altered permeability of E. coli. PLoS One 2(4): e365,
2007. PMID: 17426813. DOI: 10.1371/journal.pone.0000365
21 Spengler G, Rodrigues L, Martins A, Martins M, McCusker M,
Cerca P, Machado L, Costa SS, Ntokou E, Couto I, Viveiros M,
Fanning S, Molnar J and Amaral L: Genetic response of
Salmonella enterica serotype Enteritidis to thioridazine
rendering the organism resistant to the agent. Int J Antimicrob
Agents 39(1): 16-21, 2012. PMID: 21982147. DOI: 10.1016/
j.ijantimicag.2011.08.013 
22 Machado L, Spengler G, Evaristo M, Handzlik J, Molnar J,
Viveiros M, Kiec-Kononowicz K and Amaral L: Biological
activity of twenty-three hydantoin derivatives on intrinsic efflux
pump system of Salmonella enterica serovar Enteritidis NCTC
13349. In Vivo 25(5): 769-772, 2011. PMID: 21753132.
23 Pienaar JA, Singh A and Barnard TG: Acid-happy: Survival and
recovery of enteropathogenic Escherichia coli (EPEC) in
simulated gastric fluid. Microb Pathog 128: 396-404, 2019.
PMID: 30660737. DOI: 10.1016/j.micpath.2019.01.022 
24 Cotter PD and Hill C: Surviving the acid test: Responses of
Gram-positive bacteria to low pH. Microbiol Mol Biol Rev
67(3): 429-453, 2003. PMID: 12966143. DOI: 10.1128/mmbr.
67.3.429-453.2003
25 Amaral L, Cerca P, Spengler G, Machado L, Martins A, Couto
I, Viveiros M, Fanning S and Pages JM: Ethidium bromide
efflux by Salmonella: Modulation by metabolic energy, pH, ions
and phenothiazines. Int J Antimicrob Agents 38(2): 140-145,
2011. PMID: 21565465. DOI: 10.1016/j.ijantimicag.2011.03.014 
26 Shabayek S and Spellerberg B: Acid stress response mechanisms
of group B Streptococci. Front Cell Infect Microbiol 7(395),
2017. PMID: 28936424. DOI: 10.3389/fcimb.2017.00395
27 Sun Y, Fukamachi T, Saito H and Kobayashi H: ATP
requirement for acidic resistance in Escherichia coli. J Bacteriol
193(12): 3072-3077, 2011. PMID: 21478347. DOI: 10.1128/
JB.00091-11
28 Padan E, Zilberstein D and Rottenberg H: The proton
electrochemical gradient in Escherichia coli cells. Eur J
Biochem 63(2): 533-541, 1976. PMID: 4325. DOI:
10.1111/j.1432-1033.1976.tb10257.x
29 Mulkidjanian AY, Heberle J and Cherepanov DA: Protons @
interfaces: Implications for biological energy conversion.
Biochim Biophys Acta 1757(8): 913-930, 2006. PMID:
16624250. DOI: 10.1016/j.bbabio.2006.02.015
30 Blanco P, Sanz-Garcia F, Hernando-Amado S, Martinez JL and
Alcalde-Rico M: The development of efflux pump inhibitors to
treat gram-negative infections. Expert Opin Drug Discov 13(10):
919-931, 2018. PMID: 30198793. DOI: 10.1080/17460
441.2018.1514386 
Received September 16, 2019
Revised October 3, 2019
Accepted October 11, 2019
Nové et al: pH Dependence of Promethazine in E. coli
71
